why is this exciting? It’s just a filing for additional marketing approval....
i don’t think anyone ever said that MPCs didn’t work. It’s the inability to mass produce them at commercial scale. The continuous need for donors and screening due to inconsistency. MPCs will work well in small batches, but it’s the overall cost of treatment when compared with IPSC-MSCs that’s the real kicker.. and if we are being factual, IPSC-MSCs are actual more effective/potent if you look at the numbers.
We’ve been delayed... bit annoying, but not a fundamental problem, as is the case with bone marrow derived MSCs. It’s first generation, and fundamentally thats a problem.
Ann: Cynata Extends FUJIFILM Licence Option in GvHD, page-212
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.90M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9386 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 4500 | 1 |
View Market Depth
| Last trade - 10.25am 16/07/2024 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable